FSCD therapy meets all endpoints in interim analysis
News
Pfizer’s Talzenna therapy accepted for use within NHS Scotland
Scottish Medicines Consortium approves new option for mCRPC patients
Leqembi enters second consultation period following NICE draft guidance update
NICE convenes third committee meeting for additional appraisal consideration
NHS patients receive UK-donated plasma medicines for first time in 30 years
Octapharma supports NHS in building resilient supply chain
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements
Centauri therapeutics selects first ABX-01 clinical candidate
Lead candidate for lung infections moves to human trials
Blood cancer patients face treatment access disparity
New research highlights NHS approval gap compared to other cancers
Datapharm collaborates with VIDAL to improve medicines information access in France
New partnership to integrate SRD search technology
Brainomix partners with Medtronic to enhance stroke care
New collaboration aims to integrate AI solutions for treatment
Microbiotica unveils new data on MB097 at AACR IO meeting
Data presented in Los Angeles showcases therapy’s potential
Mitazalimab shows promising survival rates in cancer study
Updated data from phase 2 study reveals survival benefit
Rishi Sunak joins Prostate Cancer Research as an ambassador
Former UK PM advocates for national screening programme
Dubai garden blooms with Boehringer Ingelheim’s lung disease campaign
Awareness of interstitial lung disease raised at Miracle Garden
ICR researchers develop blood test to uncover how childhood tumours adapt
It is hoped that the approach will lead to more targeted treatments for childhood cancers
